Tristan Lijun Wang

Tristan Lijun Wang

R&D Intern

Followers of Tristan Lijun Wang2000 followers
location of Tristan Lijun WangShanghai, China

Connect with Tristan Lijun Wang to Send Message

Connect

Connect with Tristan Lijun Wang to Send Message

Connect
  • Timeline

  • About me

    Director

  • Education

    • China Institute of Pharmaceutical Industry

      -
      Master's degree Microbial and Biochemical Pharmacy
    • Cornell University

      -
      Master of Business Administration - MBA
    • Shanghai Jiao Tong University

      -
      Master's degree Microbial and Biochemical Pharmacy
    • Tsinghua University

      -
      Master of Business Administration - MBA
  • Experience

    • AstraZeneca

      May 2011 - Nov 2011
      R&D Intern
    • GBI

      Nov 2011 - Aug 2015
      Sr. Consultant

      Founded in Shanghai in 2002, GBI has built a diverse portfolio of market intelligence solutions for pharmaceutical and device companies and other service providers. Focused on China and the Latin American markets, GBI’s value-added industry information, news, and data services power individuals and organizations’ decision-making and enable more effective communication. As a trusted source of information, GBI has established long-term relationships with both multinational players and local firms, and continues to drive forward the health care industry.GBI has offices in Shanghai, Beijing, and Washington D.C. Show less

    • Yingke Capital (盈科资本)

      Aug 2015 - Jul 2018
      Associate Director

      Growth and late stage investment in healthcare.

    • Million Band Capital (铭朗资本)

      Jul 2018 - Nov 2020
      Senior Director

      Early stage investment in healthcare, family office

    • Qilu Pharmaceuticals

      Nov 2020 - Sept 2022
      Director

      Qilu Pharma was founded in 1958 with headquarter in Jinan, Shandong Province, and is one of the top pharmaceutical companies in China with more than 30,000 employees worldwide and over US$5 billion revenue in 2021. Qilu has set up R&D centers in Seattle, San Francisco, Boston, Shanghai and Jinan. Qilu has 30+ innovative pipelines and 200+ products in China, including 43 first-to-launch products, 30 finished products taking up the largest market share, and exports 27 high-end finished products to global markets. - Fund of funds;- Co-GP Healthcare Fund;- Corporate strategy;- Corporate investment+In-license;- Out-license;- Platform collaboration. Show less

    • Zhejiang United Investment Group (ZUIG)

      Sept 2022 - now
      Director

      Zhejiang United Investment Group (referred to as "ZUIG") is a large-scale joint-stock industrial and financial investment company, accumulating capital and financial resources from Zhejiang-based outstanding private enterprises. ZUIG draws on the guidance and support from the Zhejiang Federation of Industry and Commerce and Zhejiang Provincial Financial Service Office. The company was established in April, 2015 by eight leading Zhejiang-based private enterprises and institutions. ZUIG acts as a trailblazer into the cooperative development within the cross-industrial operations in the investment field.ZUIG's founding shareholders include CHINT Group, Futong Group, GreatStar Holding Group, Wolong Holding Group, Wanfeng Auto Holding Group, AUX Group, Sunon Group, and Hangzhou Jinjiang Group, and their businesses cover smart appliances, new energy, communications, machinery manufacturing, industrial automation, auto parts, general aviation, home appliance furniture, environmental protection, healthcare, and financial services. http://www.zuig.cn/en/http://www.zjsrfund.com/en/ Show less

  • Licenses & Certifications

    • Private Equity Qualification

    • Securities Qualification

    • TOEFL

    • TOEIC